GONIX | VMNIX | GONIX / VMNIX | |
Total Expense Ratio | 1.50 | 1.34 | 112% |
Annual Report Gross Expense Ratio | 1.92 | 1.34 | 143% |
Fund Existence | 12 years | 27 years | - |
Gain YTD | 4.847 | 3.912 | 124% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109M | 369M | 30% |
Annual Yield % from dividends | 0.00 | 5.65 | - |
Returns for 1 year | 5.52 | 0.72 | 769% |
Returns for 3 years | 39.83 | 28.03 | 142% |
Returns for 5 years | 56.99 | 53.67 | 106% |
Returns for 10 years | 49.95 | 26.19 | 191% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 37.00 | 0.19 | +0.52% |
Eventide Healthcare & Life Sciences A | |||
FGSKX | 58.41 | N/A | N/A |
Federated Hermes MDT Mid Cap Growth R6 | |||
RGAFX | 85.19 | -0.06 | -0.07% |
American Funds Growth Fund of Amer R5 | |||
UGMVX | 11.96 | -0.02 | -0.17% |
Victory Global Managed Volatility | |||
ECEIX | 12.22 | -0.12 | -0.97% |
Lazard Emerging Markets Core Equity Inst |